Trial intelligence / Profile preview

Relative Potency of Inhaled Corticosteroids Model Validation

NCT00292838Phase 4Completed

Sponsor
St. Joseph's Healthcare Hamilton
Start
Jan 2001
Primary completion
Feb 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of fluticasone propionate in asthma, eosinophilic bronchitis (EB), chronic obstructive pulmonary disease (COPD), sponsored by St. Joseph's Healthcare Hamilton. Started Jan 2001; status: completed.

02

Drugs

fluticasone propionate
03

Conditions

asthmaeosinophilic bronchitis (EB)chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT00292838.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00292838.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call